NIVF Stock Analysis: Buy, Sell, or Hold?
NIVF - NewGenIvf Group Limited Class A ordinary shares
$0.63
-0.04 (-6.25%)
▼
5d:
+8.38%
30d:
-43.75%
90d:
-63.58%
BUY
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Jun 30, 2026
6d
Get Alerted When NIVF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: NIVF shows positive signals but monitor for confirmation. Market pricing in 23.7% decline. Moderate conviction.
💡 BUY OPPORTUNITY: NIVF shows positive signals but monitor for confirmation. Market pricing in 23.7% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$3.64
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$2.26
72.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 0.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NIVF is currently trading at $0.63, which is considered slightly low relative to its 30-day fair value range of $0.61 to $0.95. From a valuation perspective, the stock is trading at a discount (Forward PE: 0.1) compared to its historical average (0.2). Remarkably, the market is currently pricing in an annual earnings decline of 23.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NIVF is in a uptrend. Immediate support is located at $0.47, while resistance sits at $1.20. Short-term momentum is weak, with the stock down 6.3% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.12 (+2001.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NIVF is in a uptrend. Immediate support is located at $0.47, while resistance sits at $1.20. Short-term momentum is weak, with the stock down 6.3% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.12 (+2001.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.61 -
$0.95
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.3%)
- BULLISH: Trading 2001.2% below Wall St target ($14.12)
Trading Range Analysis
30-Day Trading Range
$0.61 -
$0.95
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.47
Resistance Level
$1.20
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
0.07
Wall Street Target
$14.12
(+2001.2%)
Revenue Growth (YoY)
11.9%
Profit Margin
209.0%
Valuation Discount vs History
-23.7% cheaper
PE vs Historical
0.1 vs 0.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-23.7%
(market-implied from PE analysis)
1-Year Target
$0.60
(-10%)
2-Year Target
$0.54
(-19%)
3-Year Target
$0.49
(-27%)
3-Yr Target (if PE normalizes)
(PE: 0→0)
$1.36
(+103%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 97.0%)
$686.56
(+102067%)
Base:
(SPY PE: 0.1, Growth: 97.0%)
$2.27
(+238%)
Bear:
(PE: 0.1, Growth: 97.0%)
$1.93
(+187%)
📈
Valuation based on Current Earnings
Trailing PE: 0.02 | Current EPS (TTM): $36.48
Bull Case
$0.42
(-38%)
Analyst growth -50.0%, PE expands to 0.0
Base Case
$0.38
(-44%)
Market implied -50.0%, PE stable at 0.0
Bear Case
$0.52
(-23%)
Severe decline -20.0%, PE contracts to 0.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 0.1 to 0.2
Stabilization Target:
$1.87
(+178.0%)
PE Expansion Potential:
+178.0%
Share & Embed Analysis
Last updated: June 23, 2026 10:48 AM ET
Data refreshes hourly during market hours. Next update: 11:48 AM
Data refreshes hourly during market hours. Next update: 11:48 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NIVF showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 57 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$504 | 60 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 53 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 54 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 58 HOLD |
